Pregnancy or breastfeeding Moderate renal impairment (EGFR<30 mls/min/1.73m2) Hepatic impairment (ALT >3 times upper limit of the normal range) Concurrent treatment with GLP-1 receptor analogue or DPPIV inhibitor glucose-lowering therapy.